Cell-based Therapies for Corneal and Retinal Disorders

Area of Science:

• Ophthalmology and Regenerative Medicine

Background:

• Conventional ophthalmologic therapies often have limitations including partial recovery and complications.
• Ocular disorders, particularly corneal and retinal dystrophies, are significant causes of global blindness.

Purpose of the Study:

• To provide a comprehensive overview of cell-based therapies for treating corneal and retinal degenerative disorders.
• To evaluate the efficiency, drawbacks, and therapeutic strategies of various stem cell types in preclinical and clinical settings.

Main Methods:

• Review of existing literature on cell-based therapies for ocular disorders.
• Analysis of different stem cell sources, including embryonic stem cells, bone marrow stem cells, mesenchymal stem cells, and induced pluripotent stem cells.
• Examination of strategies to restore visual function using these cell therapies.

Main Results:

• Multiple stem cell types show potential for treating corneal and retinal dystrophies.
• Challenges and limitations associated with each cell therapy are identified.
• Strategies for improving efficacy and overcoming drawbacks are discussed.

Conclusions:

• Cell therapies represent a cutting-edge approach to address the root causes of blinding ocular diseases.
• Further research and clinical translation are needed to optimize these regenerative treatments for visual restoration.